Nicklaus: Biotech firms need 1,400 workers a year. St. Louis needs to find them

› St. Louis Post-Dispatch

New study aims to provide 'foundation' for St. Louis' workforce strategy in biosciences

› St. Louis Business Journal

BioSTL’s Labor Market Analysis Reveals Significant Opportunities for Accessible, Quality Jobs in Commercial Bioscience

BioGenerator portfolio tops $2.5 billion in follow-on capital for St. Louis bioscience companies

› BioSTL for St. Louis Business Journal

St. Louis Agtech Ecosystem Partners Fund New Arch Grants AgriFoodTech Track

BioGenerator Portfolio Company Wugen Doubles its Footprint in St. Louis

Nothing Impossible: BioGenerator Milestone

› KMOX NewsRadio 1120

BioGenerator-backed Wugen, which has raised $200M+ in VC funding, launches clinical trial for cancer drug

› St. Louis Business Journal

On TV: President Biden’s Cancer Moonshot is Expected to Fund Innovative Treatments in St. Louis

› HEC-TV